Vaccine and Immunology

Novel Vaccine Platforms: mRNA, DNA, and Viral Vectors

Next-generation vaccine platforms, including mRNA, DNA, and viral vectors, are transforming global immunization strategies. mRNA vaccines allow rapid synthesis of antigens, high adaptability to emerging pathogens, and strong humoral and cellular responses. DNA vaccines offer stability, cost-effectiveness, and the potential for long-term immunity. Viral vectors, including adenoviruses and lentiviruses, enable robust delivery of antigens and sustained immune activation. These platforms can be combined with novel adjuvants, nanocarriers, and controlled-release systems to enhance efficacy and durability. Advanced formulation technologies, cold-chain optimization, and scalable manufacturing enable global deployment. Regulatory frameworks, clinical evaluation, and post-marketing surveillance ensure safety, efficacy, and public confidence. By leveraging these innovative platforms, vaccines can be developed faster, tailored to emerging threats, and distributed efficiently worldwide.